Pharmacokinetics and tissue distribution of the stereoisomers of 4-methylaminorex in the rat

Journal of Pharmacology and Experimental Therapeutics

Volumn 309, Issue 3, 2004, Pages 1198-1205

  Meririnne, Esa ^a   Ellermaa, Satu ^a   Kankaanpää, Aino ^a   Bardy, Ali ^b   Seppälä, Timo ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b NATIONAL AGENCY FOR MEDICINES   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

4 METHYLAMINOREX; NOREPHEDRINE; NORPSEUDOEPHEDRINE; PSYCHOSTIMULANT AGENT;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG LIVER LEVEL; DRUG METABOLISM; DRUG MUSCLE LEVEL; GAS CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MEAN RESIDENCE TIME; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOISOMERISM; STEREOSPECIFICITY;

ANIMALS; MALE; OXAZOLES; RATS; RATS, WISTAR; STEREOISOMERISM; TISSUE DISTRIBUTION;

EID: 2442666497     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.060053     Document Type: Article

References (24)

1. Akaike H (1976) An information criterion (AIC). Math Sci 14:5-9.
2. Ashby CR Jr, Pan H, Minabe Y, Toor A, Fishkin L, and Wang RY (1995) Comparison of the actions of the stereoisomers of the psychostimulant 4-methylaminorex (4-MAX) on midbrain dopamine cells in the rat: an extracellular single unit study. Synapse 20:351-361.
3. Batsche K, Ashby CR, Lee C, Schwartz J, and Wang RY (1994) The behavioral effects of the stereoisomers of 4-methylaminorex, a psychostimulant, in the rat. J Pharmacol Exp Ther 269:1029-1039.
4. Cho AK, Hiramatsu M, Distefano EW, Chang AS, and Jenden DJ (1990) Stereochemical differences in the metabolism of 3,4-methylenedioxymethamphetamine in vivo and in vitro: a pharmacokinetic analysis. Drug Metab Dispos 18:686-691.
5. Coutts RT, Prelusky DB, and Baker GB (1984) Determination of amphetamine, norephedrine and their phenolic metabolites in rat brain by gas chromatography. J Pharm Sci 73:808-812.
6. Davis FT and Brewster ME (1988) A fatality involving U4Euh, a cyclic derivative of phenylpropanolamine. J Forensic Sci 33:549-553.
7. Federal Register, Schedules of Controlled Substances (1989) Placement of (±) cis-4-methylaminorex into schedule I. 54:14799-14800.
8. Frosch F (1977) Biopharmazeutische untersuchungen an d-norpseudoephedrin. Arzneimittelforschung 27:665-668.
9. Gaine SP, Rubin LJ, Kmetzo JJ, Palevsky HI, and Traill TA (2000) Recreational use of aminorex and pulmonary hypertension. Chest 118:1496-1497.
10. Glennon RA and Misenheimer B (1989) Stimulus properties of a new designer drug: 4-methylaminorex ('U4Euh'). Pharmacol Biochem Behav 35:517-521.
11. Henderson GL, Harkey MR, and Chueh YT (1995) Metabolism of 4-methylaminorex ('Eu4EA') in the rat. J Anal Toxicol 19:563-570.
12. Henderson MG and Fuller RW (1992) Comparative brain levels of phenylpropanolamine and amphetamine in rats. Res Commun Chem Pathol Pharmacol 75:247-250.
13. Hutchaleelaha A, Sukbuntherng J, Chow HH, and Mayersohn M (1994) Disposition kinetics of d- and l-amphetamine following intravenous administration of racemic amphetamine to rats. Drug Metab Dispos 22:406-411.
14. Kalix P (1983) A comparison of the catecholamine releasing effect of the Khat alkaloids (-)-cathinone and (+)-norpseudoephedrine. Drug Alcohol Depend 11:395-401.
15. 3H]dopamine. J Pharm Pharmacol 39:135-137.
16. Kamakura H and Satake M (1998) Pharmacokinetics of (-)-, (+)- and (±)-norephedrine. Plasma concentrations, serum protein binding and urinary excretions. Yakugaku Zasshi 118:143-149.
17. Kankaanpää A, Ellermaa S, Meririnne E, Hirsjarvi P, and Seppala T (2002) Acute neurochemical and behavioral effects of stereoisomers of 4-methylaminorex in relation to brain drug concentrations. J Pharmacol Exp Ther 300:450-459.
18. Kankaanpää A, Meririnne E, Ellermaa S, Ariniemi K, and Seppala T (2001) Detection and assay of cis- and trans-isomers of 4-methylaminorex in urine, plasma and tissue samples. Forensic Sci Int 121:57-64.
19. Klein RFX, Sperling AR, Cooper DA, and Kram TC (1989) The stereoisomers of 4-methylaminorex. J Forensic Sci 34:962-979.
20. Meyer J and Portmann P (1982) Fluorometric determination of the d-norpseudoephedrine in the plasma. Plasma levels during the resorption from the free and extended-release form. Pharm Acta Helv 57:12-15.
21. Poos GI, Carson JR, Rosenau JD, Roszkowski AP, Kelley NM, and McGowin J (1963) 2-Amino-5-aryl-2-oxazolines. Potent new anorectic agents. J Med Chem 6:266-272.
22. Quinn DI, Wodak A, and Day RO (1997) Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users. Clin Pharmacokinet 33:344-400.
23. Riviere GJ, Gentry WB, and Owens SM (2000) Disposition of methamphetamine and its metabolite amphetamine in brain and other tissues in rats after intravenous administration. J Pharmacol Exp Ther 292:1042-1047.
24. Rowland M and Tozer TN (1995) Clinical Pharmacokinetics. Concepts and Applications, 3rd ed. Lippincott Williams & Wilkins, Media, PA.